306 related articles for article (PubMed ID: 24099016)
1. Drug-induced steatohepatitis.
Patel V; Sanyal AJ
Clin Liver Dis; 2013 Nov; 17(4):533-46, vii. PubMed ID: 24099016
[TBL] [Abstract][Full Text] [Related]
2. Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease.
Rabinowich L; Shibolet O
Biomed Res Int; 2015; 2015():168905. PubMed ID: 26273591
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
Raja K; Thung SN; Fiel MI; Chang C
Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
[TBL] [Abstract][Full Text] [Related]
4. Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
López-Pascual E; Rienda I; Perez-Rojas J; Rapisarda A; Garcia-Llorens G; Jover R; Castell JV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791241
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-associated steatohepatitis.
Meunier L; Larrey D
Ann Hepatol; 2020; 19(6):597-601. PubMed ID: 32061473
[TBL] [Abstract][Full Text] [Related]
6. Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view.
Bessone F; Dirchwolf M; Rodil MA; Razori MV; Roma MG
Aliment Pharmacol Ther; 2018 Nov; 48(9):892-913. PubMed ID: 30194708
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease.
Hjelkrem MC; Torres DM; Harrison SA
Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
Milić S; Stimac D
Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
[TBL] [Abstract][Full Text] [Related]
10. [Steatosis and steatohepatitis in diabetic patient].
Hůlek P; Dresslerová I
Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver steatosis in patients with HIV infection.
Gervasoni C; Cattaneo D; Filice C; Galli M;
Pharmacol Res; 2019 Jul; 145():104267. PubMed ID: 31077811
[TBL] [Abstract][Full Text] [Related]
12. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
Ong JP; Younossi ZM
Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
[TBL] [Abstract][Full Text] [Related]
13. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Zou Y; Li J; Lu C; Wang J; Ge J; Huang Y; Zhang L; Wang Y
Life Sci; 2006 Aug; 79(11):1100-7. PubMed ID: 16624332
[TBL] [Abstract][Full Text] [Related]
14. Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies.
Amacher DE
Toxicology; 2011 Jan; 279(1-3):10-8. PubMed ID: 20974209
[TBL] [Abstract][Full Text] [Related]
15. [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].
Dray X; Tainturier MH; De La Lande P; Marty O; Mallet L
Gastroenterol Clin Biol; 2000 Nov; 24(11):1122-3. PubMed ID: 11139682
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and nonalcoholic fatty liver disease.
Ramesh S; Sanyal AJ
Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
[TBL] [Abstract][Full Text] [Related]
17. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
Salt WB
J Insur Med; 2004; 36(1):27-41. PubMed ID: 15104027
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
Mehta K; Van Thiel DH; Shah N; Mobarhan S
Nutr Rev; 2002 Sep; 60(9):289-93. PubMed ID: 12296456
[TBL] [Abstract][Full Text] [Related]
20. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
